Join us at AUA 2024!

In addition to engaging with our team at our exhibit booth, we invite you to delve into the insights presented in fourteen abstracts spotlighting our Decipher Prostate and Decipher Bladder Genomic Classifiers.

These studies offer a deep dive into the clinical applications of our Decipher tests, providing valuable guidance for treatment decisions in patients battling prostate or bladder cancer. Furthermore, our researchers will unveil fresh perspectives on the underlying biology of these cancers, gleaned through the innovative utilization of Veracyte’s whole-transcriptome-based Decipher GRID research tool.

We eagerly anticipate connecting with you at AUA 2024 and exploring the forefront of cancer diagnostics together!